EGFR and hepatocellular carcinoma: Additionally, the expression of YTHDF2 exhibits an inverse relationship with HCC cell proliferation, achieved through the activation of MEK and ERK signaling pathways and the destabilization of the Epidermal Growth Factor Receptor (EGFR) mRNA [95].